Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
For patients with mild cognitive impairment (MCI), the likelihood of progression to probable Alzheimer’s disease (AD) is important not only for individual patient care, but also for the identification of participants in clinical trial, so as to provide early interventions. Biomarkers based on various neuroimaging modalities could offer complementary information regarding different aspects of disease progression. The current study adopted a weighted multi-modality sparse representation-based classification method to combine data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, from three imaging modalities: Volumetric magnetic resonance imaging (MRI), fluorodeoxyglucose (FDG) positron emission tomography (PET), and florbetapir PET. We included 117 normal controls (NC) and 110 MCI patients, 27 of whom progressed to AD within 36 months (pMCI), while the remaining 83 remained stable (sMCI) over the same time period. Modality-specific biomarkers were identified to distinguish MCI from NC and to predict pMCI among MCI. These included the hippocampus, amygdala, middle temporal and inferior temporal regions for MRI, the posterior cingulum, precentral, and postcentral regions for FDG-PET, and the hippocampus, amygdala, and putamen for florbetapir PET. Results indicated that FDG-PET may be a more effective modality in discriminating MCI from NC and in predicting pMCI than florbetapir PET and MRI. Combining modality-specific sensitive biomarkers from the three modalities boosted the discrimination accuracy of MCI from NC (76.7%) and the prediction accuracy of pMCI (82.5%) when compared with the best single-modality results (73.6% for MCI and 75.6% for pMCI with FDG-PET).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802 · cited 1×
“The middle temporal and inferior temporal regions for MRI, and the posterior cingulum, precentral, and postcentral regions for FDG-PET were shown to be biomarkers for MCI and pMCI, indicating that changes in these regions may occur primarily in the progressive stage but not in the early (or stable) stage of MCI, consi…”
Grundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972 · cited 1×
“Mild cognitive impairment (MCI) has been suggested as the precursor stage of Alzheimer’s disease (AD) because of the probable conversion to AD [1, 2].”
Comparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e8b8 · Cited by 616
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007) · Brain · doi:10.1093/brain/awm112 · Cited by 607 · cited 2×
“Many of these biomarkers have been indicated as significant in MCI patients in previous studies [10, 17, 43, 45–50], and combining these biomark-”
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort
Risacher, S., Saykin, A., Wes, J., Shen, L., Firpi, H., & McDonald, B. (2009) · Current Alzheimer Research · doi:10.2174/156720509788929273 · Cited by 538 · cited 1×
“revealed that besides decreased hippocampal volume being a robust biomarker to predict MCI, the medial temporal structure was also a promising MRI marker for the same purpose [13].”
Fan, Y., Batmanghelich, N., Clark, C. M., & Davatzikos, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.031 · Cited by 477 · cited 1×
“considered spatial patterns of brain atrophy including the hippocampus, medial temporal lobe, orbitofrontal, and medial prefrontal grey matter to identify MCI patients [10]; Zhang et al.”
A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease
Sexton, C. E., Kalu, U. G., Filippini, N., Mackay, C. E., & Ebmeier, K. P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.019 · Cited by 410
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
Whitwell, J. L., Shiung, M. M., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000280575.77437.a2 · Cited by 357 · cited 2×
“Besides the criteria of the National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer’s Disease and Related Disorders Association (NINCDS/ADRDA) [4], biomarkers from various neuroimaging modalities have been increasingly suggested as of utility in predicting MCI and pMCI [5–8].”
Cited by
Advances in multimodal data fusion in neuroimaging: Overview, challenges, and novel orientation
Zhang, Y.-D., Dong, Z., Wang, S.-H., Yu, X., Yao, X., Zhou, Q., Hu, H., Li, M., Jiménez-Mesa, C., Ramirez, J., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.07.006 · Cited by 453
Lombardi, G., Crescioli, G., Cavedo, E., Lucenteforte, E., Casazza, G., Bellatorre, A.-G., Lista, C., Costantino, G., Frisoni, G., Virgili, G., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009628.pub2 · Cited by 214
Ansart, M., Epelbaum, S., Bassignana, G., Bône, A., Bottani, S., Cattai, T., Couronné, R., Faouzi, J., Koval, I., Louis, M., et al. (2021) · Medical Image Analysis · doi:10.1016/j.media.2020.101848 · Cited by 116
Thung, K.-H., Yap, P.-T., Adeli, E., Lee, S.-W., & Shen, D. (2018) · Medical Image Analysis · doi:10.1016/j.media.2018.01.002 · Cited by 89
Metadata
- Authors
- Xu, L., Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., Yao, L., & Initiative, T. A. D. N.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-02-25
- Volume
- 51
- Issue
- 4
- Pages
- 1045-1056
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2290144698
- Cited by
- 76
- References
- 8
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers. https://app.cochat.ai/papers/10.3233/jad-151010
- The paper
- Xu, L., Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., Yao, L., & Initiative, T. A. D. N. (2016). Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-151010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.